Literature DB >> 25452166

Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris.

Xi Wang1, Kai Cao, Xin Sun, Yongxiong Chen, Zhaoxia Duan, Li Sun, Lei Guo, Paul Bai, Dongming Sun, Jianqing Fan, Xijing He, Wise Young, Yi Ren.   

Abstract

Macrophage activation and persistent inflammation contribute to the pathological process of spinal cord injury (SCI). It was reported that M2 macrophages were induced at 3-7 days after SCI but M2 markers were reduced or eliminated after 1 week. By contrast, M1 macrophage response is rapidly induced and then maintained at injured spinal cord. However, factors that modulate macrophage phenotype and function are poorly understood. We developed a model to distinguish bone-marrow derived macrophages (BMDMs) from residential microglia and explored how BMDMs change their phenotype and functions in response to the lesion-related factors in injured spinal cord. Infiltrating BMDMs expressing higher Mac-2 and lower CX3CR1 migrate to the epicenter of injury, while microglia expressing lower Mac-2 but higher CX3CR1 distribute to the edges of lesion. Myelin debris at the lesion site switches BMDMs from M2 phenotype towards M1-like phenotype. Myelin debris activates ATP-binding cassette transporter A1 (ABCA1) for cholesterol efflux in response to myelin debris loading in vitro. However, this homeostatic mechanism in injured site is overwhelmed, leading to the development of foamy macrophages and lipid plaque in the lesion site. The persistence of these cells indicates a pro-inflammatory environment, associated with enhanced neurotoxicity and impaired wound healing. These foamy macrophages have poor capacity to phagocytose apoptotic neutrophils resulting in uningested neutrophils releasing their toxic contents and further tissue damage. In conclusion, these data demonstrate for the first time that myelin debris generated in injured spinal cord modulates macrophage activation. Lipid accumulation following macrophage phenotype switch contributes to SCI pathology.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  foamy cells; macrophages; myelin debris; spinal cord injury

Mesh:

Substances:

Year:  2014        PMID: 25452166      PMCID: PMC4331228          DOI: 10.1002/glia.22774

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  72 in total

Review 1.  Apoptosis: the importance of being eaten.

Authors:  Y Ren; J Savill
Journal:  Cell Death Differ       Date:  1998-07       Impact factor: 15.828

Review 2.  The chemokine system in diverse forms of macrophage activation and polarization.

Authors:  Alberto Mantovani; Antonio Sica; Silvano Sozzani; Paola Allavena; Annunciata Vecchi; Massimo Locati
Journal:  Trends Immunol       Date:  2004-12       Impact factor: 16.687

Review 3.  ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.

Authors:  John F Oram; Jay W Heinecke
Journal:  Physiol Rev       Date:  2005-10       Impact factor: 37.312

4.  High cholesterol level is essential for myelin membrane growth.

Authors:  Gesine Saher; Britta Brügger; Corinna Lappe-Siefke; Wiebke Möbius; Ryu-ichi Tozawa; Michael C Wehr; Felix Wieland; Shun Ishibashi; Klaus-Armin Nave
Journal:  Nat Neurosci       Date:  2005-03-27       Impact factor: 24.884

5.  Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats.

Authors:  Yi Zhao; Andreas Patzer; Thomas Herdegen; Peter Gohlke; Juraj Culman
Journal:  FASEB J       Date:  2006-06       Impact factor: 5.191

6.  Spinal cord injury is accompanied by chronic progressive demyelination.

Authors:  Minodora O Totoiu; Hans S Keirstead
Journal:  J Comp Neurol       Date:  2005-06-13       Impact factor: 3.215

Review 7.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.

Authors:  Yoon Seong Kim; Tong H Joh
Journal:  Exp Mol Med       Date:  2006-08-31       Impact factor: 8.718

8.  The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.

Authors:  R M Lawn; D P Wade; M R Garvin; X Wang; K Schwartz; J G Porter; J J Seilhamer; A M Vaughan; J F Oram
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 9.  Neutrophil-derived cytokines: potential therapeutic targets in inflammation.

Authors:  Tsuyoshi Kasama; Yusuke Miwa; Takeo Isozaki; Tsuyoshi Odai; Mitsuru Adachi; Steven L Kunkel
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-06

Review 10.  Phagocytosis of myelin in demyelinative disease: a review.

Authors:  M E Smith
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more
  86 in total

1.  Deletion of the Fractalkine Receptor, CX3CR1, Improves Endogenous Repair, Axon Sprouting, and Synaptogenesis after Spinal Cord Injury in Mice.

Authors:  Camila M Freria; Jodie C E Hall; Ping Wei; Zhen Guan; Dana M McTigue; Phillip G Popovich
Journal:  J Neurosci       Date:  2017-03-06       Impact factor: 6.167

2.  TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.

Authors:  Jamie S Church; Kristina A Kigerl; Jessica K Lerch; Phillip G Popovich; Dana M McTigue
Journal:  J Neurosci       Date:  2016-06-08       Impact factor: 6.167

Review 3.  Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury.

Authors:  Timothy J Kopper; John C Gensel
Journal:  J Neurosci Res       Date:  2017-07-11       Impact factor: 4.164

Review 4.  The origin, fate, and contribution of macrophages to spinal cord injury pathology.

Authors:  Lindsay M Milich; Christine B Ryan; Jae K Lee
Journal:  Acta Neuropathol       Date:  2019-03-30       Impact factor: 17.088

5.  Neural Stem Cell-Conditioned Medium Suppresses Inflammation and Promotes Spinal Cord Injury Recovery.

Authors:  Zhijian Cheng; Dale B Bosco; Li Sun; Xiaoming Chen; Yunsheng Xu; Wenjiao Tai; Ruth Didier; Jinhua Li; Jianqing Fan; Xijing He; Yi Ren
Journal:  Cell Transplant       Date:  2016-10-12       Impact factor: 4.064

Review 6.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

7.  In Vitro Phagocytosis of Myelin Debris by Bone Marrow-Derived Macrophages.

Authors:  Alyssa J Rolfe; Dale B Bosco; Erynn N Broussard; Yi Ren
Journal:  J Vis Exp       Date:  2017-12-30       Impact factor: 1.355

Review 8.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

9.  The role of the immune system during regeneration of the central nervous system.

Authors:  K Z Sabin; K Echeverri
Journal:  J Immunol Regen Med       Date:  2019-11-05

10.  Reducing age-dependent monocyte-derived macrophage activation contributes to the therapeutic efficacy of NADPH oxidase inhibition in spinal cord injury.

Authors:  Bei Zhang; William M Bailey; Anna Leigh McVicar; Andrew N Stewart; Amy K Veldhorst; John C Gensel
Journal:  Brain Behav Immun       Date:  2018-11-16       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.